Follow on Extension of XT-150-1-0201
Clinical trial NCT03769662 · COMPLETED
Trial details
- NCT number
- NCT03769662
- Sponsor
- Xalud Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2019-10-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.